Radiotherapy and chemotherapy for myoepithelioma of the sellar region

Carsten Nieder, Folker Schneller, Anca L. Grosu, Christian Peschel, Michael Molls

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Background: Myoepithelioma might arise in the head and neck area, especially within the salivary glands. It is very uncommon as a primary intracranial tumor. Case Report: A 34-year-old African patient with proliferating myoepithelioma originating in the sellar region is described. After subtotal resection, the tumor recurred locally despite postoperative radiotherapy to a total dose of 54 Gy (Figures 1 and 2). When intracranial metastases developed, chemotherapy with ifosfamide and, later, BCNU was administered. No objective response was obtained with any of the nonsurgical approaches. Uncontrolled intracranial tumor growth led to the patient's death 20 months after the initial diagnosis. Conclusion: Most tumors of the sellar region have a favorable prognosis. However, this case of incompletely resected proliferating myoepithelioma showed both local and distant recurrences, which did not respond to further treatment. Thus, complete surgical resection is recommended, whenever technically feasible.

Original languageEnglish
Pages (from-to)260-263
Number of pages4
JournalStrahlentherapie und Onkologie
Volume181
Issue number4
DOIs
StatePublished - Apr 2005

Keywords

  • Brain tumor
  • Chemotherapy
  • Myoepithelioma
  • Radiotherapy
  • Sellar tumor

Fingerprint

Dive into the research topics of 'Radiotherapy and chemotherapy for myoepithelioma of the sellar region'. Together they form a unique fingerprint.

Cite this